Published in J Pediatr on March 01, 2007
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" | NCT04684667
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
Hemangiomas and vascular malformations: current theory and management. Int J Pediatr (2012) 2.49
Incidence and clinical characteristics of periocular infantile hemangiomas. Arch Ophthalmol (2012) 1.38
Hemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics. Pediatr Radiol (2011) 1.28
Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med (2011) 1.19
Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr (2010) 1.13
Vasculogenesis in infantile hemangioma. Angiogenesis (2009) 1.11
Signaling mechanisms in infantile hemangioma. Curr Opin Hematol (2009) 1.00
Update on pediatric extracranial vascular anomalies of the head and neck. Childs Nerv Syst (2010) 0.98
Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol (2014) 0.96
Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China. Eur J Pediatr (2013) 0.94
Biology of infantile hemangioma. Front Surg (2014) 0.94
Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med (2012) 0.91
Complex vascular anomalies. Pediatr Surg Int (2013) 0.87
Infantile hemangiomas: A review. Saudi J Ophthalmol (2012) 0.85
Radiographic findings associated with vascular anomalies. Semin Plast Surg (2014) 0.84
A potential role for notch signaling in the pathogenesis and regulation of hemangiomas. J Craniofac Surg (2009) 0.83
Vascular anomalies of the head and neck in children. Quant Imaging Med Surg (2015) 0.83
Multimodality imaging of vascular anomalies. Pediatr Radiol (2013) 0.82
Embolization in the head and neck. Semin Intervent Radiol (2008) 0.82
Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients. Drug Des Devel Ther (2015) 0.81
Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies. Acta Otorhinolaryngol Ital (2012) 0.80
Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial. Adv Biomed Res (2015) 0.80
Copy number variation analysis in 98 individuals with PHACE syndrome. J Invest Dermatol (2012) 0.79
Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from oman. Middle East Afr J Ophthalmol (2011) 0.79
Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr (2015) 0.79
Mechanisms of propranolol action in infantile hemangioma. Dermatoendocrinol (2015) 0.78
Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma. Drugs Real World Outcomes (2015) 0.78
Role of connexins in infantile hemangiomas. Front Pharmacol (2013) 0.78
A retrospective study to classify surgical indications for infantile hemangiomas. J Plast Reconstr Aesthet Surg (2014) 0.77
Successful and safe treatment of hemangioma with oral propranolol in a single institution. Korean J Pediatr (2012) 0.76
Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis. Eur J Pediatr (2013) 0.76
Excellent response of infantile orbital hemangioma to propranolol. Int Med Case Rep J (2016) 0.76
Excellent response of infantile orofacio-orbital hemangioma to propranolol-pictorial depiction and literature review. Contemp Clin Dent (2016) 0.75
X Chromosome-Inactivation Patterns in 31 Individuals with PHACE Syndrome. Mol Syndromol (2012) 0.75
Beta-blockers as therapy for infantile hemangiomas. Semin Plast Surg (2014) 0.75
[Drugs news]. Arch Pediatr (2015) 0.75
Imaging and percutaneous treatment of vascular anomalies. Semin Intervent Radiol (2008) 0.75
Mimics of duplication cysts: intraperitoneal nodules in a 14-year-old boy. Clin Med Insights Pediatr (2015) 0.75
Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol (2015) 0.75
Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders. Int J Exp Pathol (2016) 0.75
Biomechanical properties of infantile hemangiomas: clinical stage and effect of age. Skin Res Technol (2016) 0.75
Imaging Pediatric Vascular Lesions. J Clin Aesthet Dermatol (2015) 0.75
What is your diagnosis? J Turk Ger Gynecol Assoc (2014) 0.75
Novel mutations in one allele in a Chinese family with neurofibromatosis type 1: Including a complex insertion-deletion mutation. J Dermatol (2016) 0.75
Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody. Int J Nanomedicine (2017) 0.75
Adult neck hemangiolymphangioma: a case and review of its etiology, diagnosis and management. J Surg Case Rep (2017) 0.75
Infantile Periocular Hemangioma. J Ophthalmic Vis Res (2017) 0.75
The expression and function of miR-424 in infantile skin hemangioma and its mechanism. Sci Rep (2017) 0.75
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet (2012) 4.51
A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med (2015) 4.05
Guidelines of care for acne vulgaris management. J Am Acad Dermatol (2007) 2.80
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol (2002) 2.41
Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol (2007) 2.31
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer (2012) 2.29
Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics (2006) 2.28
Physiologic changes in vascular birthmarks during early infancy: Mechanisms and clinical implications. J Am Acad Dermatol (2009) 2.26
Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science (2010) 2.21
Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol (2008) 2.12
Pubertal correlates in black and white girls. J Pediatr (2006) 2.12
Hemorrhagic, bullous Henoch Schonlein purpura in a 16-year-old girl with previously undiagnosed dominant dystrophic epidermolysis bullosa. Pediatr Dermatol (2010) 2.08
Response of tufted angiomas to low-dose aspirin. Pediatr Dermatol (2012) 2.04
Trichotillomania in childhood: case series and review. Pediatrics (2004) 2.02
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat (2008) 2.00
Infantile transient smooth muscle contraction of the skin. J Am Acad Dermatol (2013) 1.95
Growth characteristics of infantile hemangiomas: implications for management. Pediatrics (2008) 1.95
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol (2002) 1.94
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics (2012) 1.91
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol (2005) 1.77
Vascular malformations: Part I. J Am Acad Dermatol (2007) 1.74
Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol (2002) 1.62
Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics (2010) 1.60
Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty. J Pediatr (2003) 1.59
Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol (2005) 1.58
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics (2013) 1.57
Surgical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol (2007) 1.56
Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol (2008) 1.56
Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature. J Neurosurg (2005) 1.54
Segmental neurofibromatosis in childhood. Am J Med Genet A (2003) 1.53
Hemangiomas of infancy. J Am Acad Dermatol (2003) 1.53
Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol (2002) 1.49
Pseudoacne of the nasal crease: a new entity? Pediatr Dermatol (2004) 1.49
Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic". Pediatr Dermatol (2012) 1.48
Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr (2013) 1.48
Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol (2010) 1.47
Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol (2013) 1.43
Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics (2005) 1.43
Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol (2009) 1.42
Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. J Invest Dermatol (2012) 1.41
Retrospective review of adverse effects from propranolol in infants. JAMA Dermatol (2013) 1.40
Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet (2012) 1.40
The Cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip. Plast Reconstr Surg (2010) 1.39
Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study. Pediatr Dermatol (2010) 1.39
Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol (2010) 1.38
The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol (2008) 1.36
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol (2009) 1.31
Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics (2005) 1.28
Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics (2006) 1.24
Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol (2008) 1.23